Effect of platelet activating factor on hepatic capillary pressure in isolated dog liver

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 3, 1997, Pages 293-298

  Wang, H G ^a   Shibamoto, T ^a   Koyama, S ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; CAPILLARY PRESSURE; CONTROLLED STUDY; DOG; DOSE RESPONSE; IN VITRO STUDY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED LIVER; LIVER WEIGHT; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALIA; CANIS FAMILIARIS; TRIXIS;

EID: 0030698845     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90547-0     Document Type: Article

References (31)

1. Hanahan D. J. Platelet-activating factor: a biological active phosphoglyceride. Annu Rev Biochem 1986; 55: 483-589.
2. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspective in platelet-activating factor research. Pharmacol Rev 1987; 39: 97-145.
3. Kitagawa S., Kubota Y., Yamaguchi T. et al. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats. J Gastroentero Hepatol 1992; 7: 481-485.
4. Guarner F., Wallace J. L., MacNaughton W. K., Ibbotson G. C., Arroyo V., Rodes J. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. Hepatology 1989; 10: 788-794.
5. Wang K.-S., Monden M., Kanai T. et al. Protective effects of a PAF antagonist against liver injury induced by warm ischemia or cold preservation. Transplant Proc 1992; 24: 1596-1598.
6. Ontell S. J., Makowka L., Trager J., Mazzaferro V., Ove P., Starzl T. E. Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg 1989; 209: 200-210.
7. Bessin P., Bonnet J., Apffel D. et al. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur J Pharmacol 1983; 86: 403-413.
8. Hines K. L., Braillon A., Fisher R. A. PAF increases hepatic vascular resistance and glycogenolysis in vivo. Am J Physiol 1991; 260: G471-G480.
9. Lapointe D. S., Olson M. S. Alteration of hepatic tissue spaces by platelet-activating factor and phenylephrine. Hematology 1989; 9: 278-284.
10. Buxton D. B., Fisher R. A., Hanahan D. J., Olson M. S. Platelet-activating factor mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem 1986; 261: 644-649.
11. Bohlen H. G., Maass-Moreno R, Rothe C. F. Hepatic venular pressures of rats, dogs, and rabbits. Am J Physiol 1991; 261: G539-G547.
12. Shibayama Y., Nakata K. Localization of increased hepatic vascular resistance in liver cirrhosis. Hepatology 1985; 5: 643-648.
13. Legare D. J., Lautt W. W. Hepatic venous resistance site in the dog: localization and validation of intrahepatic pressure measurement. Can J Physiol Pharmacol 1987; 65: 352-359.
14. Yamaguchi Y., Shibamoto T., Hayashi T., Saeki Y., Tanaka S. Hepatic vascular response to anaphylaxis in isolated canine liver. Am J Physiol 1994; 267: R268-R274.
15. Shibamoto T., Wang H.-G., Tanaka S., Koyama S. Hepatic capillary pressure is estimated using triple vascular occlusion method in isolated canine liver. Am J Physiol 1996; 271: R1130-R1141.
16. Taylor A. E., Granger N. Exchange of macromolecules across the microcirculation. In: Renkin E. M., Michel C. C. eds. Handbook of Physiology. The Cardiovascular System. Microcirculation. Sect. 2, vol. IV, pt. 1, chapt. 11. Bethesda: American Physiological Society, 1984:467.
17. Bazzoni G., Beltran N. A., Mascellani G., Bianchini P., Dejana E., Del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 1993; 121: 268-275.
18. Khuri S. F., Valeri C. R., Loscalzo J et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1008-1014.
19. Mendlovic F., Corvera S., Garcia-Sainz J. A. Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. Biochem Biophys Res Commun 1984; 123: 507-514.
20. 2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-α-lysophosphatidylcoline in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. Biochem J 1987; 245: 145-150.
21. Chao W., Liu H., DeBuysere M., Hanahan D. J., Olson M. S. Identification of receptors for platelet-activating factor in rat Kupffer cells. J Biol Chem 1989; 264: 13591-13598.
22. 2 analogue contracts predominantly the hepatic veins in isolated canine livers. Prostaglandins 1996; 52: 483-495.
23. Kawada N., Tran-Thi T.-A., Klein H., Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances: possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoid tonus. Eur J Biochem 1993; 213: 815-823.
24. Wake K. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int Rev Cytol 1980; 66: 303-353.
25. Shibamoto T., Yamaguchi Y., Hayashi T., Saeki Y., Kawamoto M., Koyama S. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. Am J Physiol 1993; 264: H1454-H1459.
26. Matsuda Y., Shibamoto T., Hayashi T. Jr et al. Renal vascular and sympathetic nerve responses to hypotension induced by platelet-activating factor in anesthetized dogs. Eur J Pharmacol 1993; 250: 341-347.
27. Dillon P. K., Ritter A. B., Duran W. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: Dose-related relations and pathways of action. Circ Res 1988; 62: 722-731.
28. Sybertz E. J., Watkins R. W., Baum T., Pula K., Rivelli M. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. J Pharmacol Exp Ther 1985; 232: 156-162.
29. Chu K. M., Gerber J. G., Nies A. S. Local vasodilator effect of platelet-activating factor in the gastric, mesenteric and femoral arteries of the dog. J Pharmacol Exp Ther 1988; 246: 996-1000.
30. Schwertschlag U., Scherf H., Gerber J. G., Mathias M., Nies A. S. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. Circ Res 1987; 60: 534-539.
31. Claing A., Bkaily G., Berthiaume N., Sirois P., Rola-Pleszczynski M., D'Orleans-Juste P. Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor. Br J Pharmacol 1994; 112: 1202-1208.